Cambridge, Massachusetts
United States
125
2023-11-16
110
2024-11-26
These are the the leading inventors for applications assigned to INFINITY PHARMACEUTICALS, INC.:
INFINITY PHARMACEUTICALS, INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#2 | 2022-11-24 ✅ Patent 12,152,032 granted on 2024-11-26Heterocyclic compounds and uses thereof
#3 | 2022-05-05 ✅ Patent 11,939,333 granted on 2024-03-26Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
#4 | 2022-04-28 ✅ Patent 11,944,631 granted on 2024-04-02Combination therapies
#5 | 2021-09-09 ✅ Patent 11,602,527 granted on 2023-03-14Methods of use of cyclopamine analogs
#6 | 2021-03-04 ✅ Patent 12,213,983 granted on 2025-02-04Treatment of cancers using PI3 kinase isoform modulators
#7 | 2021-01-07 ✅ Patent 11,541,059 granted on 2023-01-03Heterocyclic compounds and uses thereof
#8 | 2020-12-10 ✅ Patent 11,312,718 granted on 2022-04-26Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
#9 | 2020-04-23 ✅ Patent 11,007,181 granted on 2021-05-18Cyclopamine analogs
#10 | 2020-01-23 ✅ Patent 10,821,102 granted on 2020-11-03Methods of use of cyclopamine analogs
#11 | 2019-10-31 ✅ Patent 10,941,162 granted on 2021-03-09Heterocyclic compounds and uses thereof
#12 | 2019-07-18 ✅ Patent 11,147,818 granted on 2021-10-19Combination therapies
#13 | 2019-07-04 ✅ Patent 10,759,806 granted on 2020-09-01Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
#14 | 2019-06-20 ✅ Patent 11,247,995 granted on 2022-02-15Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
#15 | 2019-05-09 ✅ Patent 10,919,914 granted on 2021-02-16Heterocyclic compounds and uses thereof
#16 | 2019-01-03 ✅ Patent 10,406,139 granted on 2019-09-10Cyclopamine analogs
#17 | 2018-11-29 ✅ Patent 10,314,827 granted on 2019-06-11Methods of use of cyclopamine analogs
#18 | 2018-09-27 ✅ Patent 10,550,122 granted on 2020-02-04Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one and methods of use thereof
#19 | 2018-03-01 ✅ Patent 10,675,286 granted on 2020-06-09Heterocyclic compounds and uses thereof
#20 | 2018-03-01 ✅ Patent 11,110,096 granted on 2021-09-07Combination therapies
#21 | 2018-02-15 ✅ Patent 10,329,299 granted on 2019-06-25Heterocyclic compounds and uses thereof
#22 | 2017-12-28 ✅ Patent 10,253,047 granted on 2019-04-09Heterocyclic compounds and uses thereof
#23 | 2017-12-21TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#24 | 2017-12-21 ✅ Patent 10,045,970 granted on 2018-08-14Methods of use of cyclopamine analogs
#25 | 2017-03-30 ✅ Patent 10,160,761 granted on 2018-12-25Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
#26 | 2017-02-02 ✅ Patent 9,879,025 granted on 2018-01-30Transfer hydrogenation of cyclopamine analogs
#27 | 2017-01-26 ✅ Patent 9,951,083 granted on 2018-04-24Cyclopamine analogs
#28 | 2016-08-04 ✅ Patent 9,751,888 granted on 2017-09-05Heterocyclic compounds and uses thereof
#29 | 2016-06-23 ✅ Patent 9,879,293 granted on 2018-01-30Enzymatic transamination of cyclopamine analogs
#30 | 2016-06-09 ✅ Patent 9,669,011 granted on 2017-06-06Methods of use of cyclopamine analogs
#31 | 2016-06-02 ✅ Patent 9,840,505 granted on 2017-12-12Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof
#32 | 2016-05-05 ✅ Patent 9,708,348 granted on 2017-07-18Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
#33 | 2016-04-28TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#34 | 2016-01-21 ✅ Patent 9,738,644 granted on 2017-08-22Chemical compounds, compositions and methods for kinase modulation
#35 | 2015-12-24INHIBITORS OF FATTY ACID AMIDE HYDROLASE
#36 | 2015-10-15 ✅ Patent 9,775,844 granted on 2017-10-03Heterocyclic compounds and uses thereof
#37 | 2015-10-08TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#38 | 2015-09-03 ✅ Patent 9,605,003 granted on 2017-03-28Heterocyclic compounds and uses thereof
#39 | 2015-08-27 ✅ Patent 9,951,089 granted on 2018-04-24Methods of treating a fatty acid amide hydrolase-mediated condition
#40 | 2015-08-13 ✅ Patent 9,828,377 granted on 2017-11-28Heterocyclic compounds and uses thereof
#41 | 2015-05-07 ✅ Patent 9,718,815 granted on 2017-08-01Heterocyclic compounds and uses thereof
#42 | 2015-04-23 ✅ Patent 9,359,365 granted on 2016-06-07Heterocyclic compounds and uses thereof
#43 | 2015-04-16 ✅ Patent 9,255,108 granted on 2016-02-09Heterocyclic compounds and uses thereof
#44 | 2015-01-29 ✅ Patent 9,388,183 granted on 2016-07-12Heterocyclic compounds and uses thereof
#45 | 2014-12-25Treatment Of Cancers Using PI3 Kinase Isoform Modulators
#46 | 2014-12-18 ✅ Patent 9,290,497 granted on 2016-03-22Processes for preparing isoquinolinones and solid forms of isoquinolinones
#47 | 2014-12-18 ✅ Patent 9,492,435 granted on 2016-11-15Cyclopamine analogs
#48 | 2014-12-04 ✅ Patent 9,238,672 granted on 2016-01-19Methods for stereoselective reduction
#49 | 2014-11-20 ✅ Patent 9,527,847 granted on 2016-12-27Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
#50 | 2014-09-25 ✅ Patent 9,546,180 granted on 2017-01-17Heterocyclic compounds and uses thereof
#51 | 2014-09-18 ✅ Patent 9,481,667 granted on 2016-11-01Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
#52 | 2014-08-21 ✅ Patent 9,630,979 granted on 2017-04-25Inhibitors of monoacylglycerol lipase and methods of their use
#53 | 2014-05-01 ✅ Patent 9,108,989 granted on 2015-08-18Inhibitors of fatty acid amide hydrolase
#54 | 2014-05-01TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#55 | 2014-05-01TREATMENT OF RHEUMATOID ARTHRITIS AND ASTHMA USING PI3 KINASE INHIBITORS
#56 | 2014-04-17 ✅ Patent 9,145,422 granted on 2015-09-29Methods of use of cyclopamine analogs
#57 | 2014-04-10 ✅ Patent 9,115,141 granted on 2015-08-25Substituted isoquinolinones and methods of treatment thereof
#58 | 2014-03-27 ✅ Patent 9,181,221 granted on 2015-11-10Chemical compounds, compositions and methods for kinase modulation
#59 | 2014-03-20 ✅ Patent 9,346,769 granted on 2016-05-24Tetrazolones as inhibitors of fatty acid synthase
#60 | 2013-12-26 ✅ Patent 8,802,064 granted on 2014-08-12Inhibitors of fatty acid amide hydrolase
#61 | 2013-12-26 ✅ Patent 8,828,998 granted on 2014-09-09Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
#62 | 2013-12-19 ✅ Patent 8,802,119 granted on 2014-08-12Inhibitors of fatty acid amide hydrolase
#63 | 2013-10-10 ✅ Patent 8,940,742 granted on 2015-01-27Heterocyclic compounds and uses thereof
#64 | 2013-09-19TRIAZOLES AS INHIBITORS OF FATTY ACID SYNTHASE
#65 | 2013-08-08 ✅ Patent 8,703,755 granted on 2014-04-22Analogs of benzoquinone-containing ansamycins and methods of use thereof
#66 | 2013-05-23 ✅ Patent 8,609,706 granted on 2013-12-17Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
#67 | 2013-05-02 ✅ Patent 8,895,576 granted on 2014-11-25Methods of use of cyclopamine analogs
#68 | 2013-03-07 ✅ Patent 8,629,125 granted on 2014-01-14Inhibitors of fatty acid amide hydrolase
#69 | 2013-02-28 ✅ Patent 8,785,470 granted on 2014-07-22Heterocyclic compounds and uses thereof
#70 | 2013-01-31 ✅ Patent 9,056,877 granted on 2015-06-16Heterocyclic compounds and uses thereof
#71 | 2013-01-31 ✅ Patent 8,969,363 granted on 2015-03-03Heterocyclic compounds and uses thereof
#72 | 2012-07-19 ✅ Patent 8,809,349 granted on 2014-08-19Processes for preparing isoquinolinones and solid forms of isoquinolinones
#73 | 2012-05-17 ✅ Patent 8,901,133 granted on 2014-12-02Heterocyclic compounds and uses thereof
#74 | 2012-05-10 ✅ Patent 9,062,116 granted on 2015-06-23Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
#75 | 2012-05-03Methods Of Treating Liposarcoma
#76 | 2012-04-19 ✅ Patent 8,546,564 granted on 2013-10-01Inhibitors of fatty acid amide hydrolase
#77 | 2012-04-12 ✅ Patent 8,541,581 granted on 2013-09-24Inhibitors of fatty acid amide hydrolase
#78 | 2012-04-05 ✅ Patent 8,703,448 granted on 2014-04-22Enzymatic transamination of cyclopamine analogs
#79 | 2012-03-29 ✅ Patent 8,227,509 granted on 2012-07-24Methods of use of cyclopamine analogs
#80 | 2012-03-15 ✅ Patent 9,376,447 granted on 2016-06-28Transfer hydrogenation of cyclopamine analogs
#81 | 2012-03-15 ✅ Patent 9,394,313 granted on 2016-07-19Transfer hydrogenation of cyclopamine analogs
#82 | 2012-03-08 ✅ Patent 8,604,032 granted on 2013-12-10Chemical compounds, compositions and methods for kinase modulation
#83 | 2012-03-08 ✅ Patent 8,252,779 granted on 2012-08-28Analogs of benzoquinone-containing ansamycins and methods of use thereof
#84 | 2011-11-10 ✅ Patent 8,546,432 granted on 2013-10-01Tetrazolones as inhibitors of fatty acid synthase
#85 | 2011-11-10 ✅ Patent 8,450,350 granted on 2013-05-28Triazoles as inhibitors of fatty acid synthase
#86 | 2011-10-27 ✅ Patent 8,778,921 granted on 2014-07-15Ansamycin hydroquinone compositions
#87 | 2011-09-22 ✅ Patent 8,349,814 granted on 2013-01-08Inhibitors of fatty acid amide hydrolase
#88 | 2011-09-15 ✅ Patent 8,329,675 granted on 2012-12-11Inhibitors of fatty acid amide hydrolase
#89 | 2011-09-01 ✅ Patent 8,178,690 granted on 2012-05-15Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
#90 | 2011-08-18 ✅ Patent 9,034,849 granted on 2015-05-19Fatty acid amide hydrolase inhibitors
#91 | 2011-07-28TREATMENT OF FIBROTIC CONDITIONS USING HEDGEHOG INHIBITORS
#92 | 2011-07-14 ✅ Patent 8,957,049 granted on 2015-02-17Inhibitors of fatty acid amide hydrolase
#93 | 2011-07-07 ✅ Patent 8,236,956 granted on 2012-08-07Cyclopamine analogues and methods of use thereof
#94 | 2011-06-30 ✅ Patent 8,461,191 granted on 2013-06-11Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
#95 | 2011-05-19COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER
#96 | 2011-04-14 ✅ Patent 8,003,634 granted on 2011-08-23Analogs of benzoquinone-containing ansamycins and methods of use thereof
#97 | 2011-02-10 ✅ Patent 8,765,735 granted on 2014-07-01Isoxazolines as inhibitors of fatty acid amide hydrolase
#98 | 2011-02-03 ✅ Patent 8,927,551 granted on 2015-01-06Isoxazolines as inhibitors of fatty acid amide hydrolase
#99 | 2011-02-03 ✅ Patent 9,149,465 granted on 2015-10-06Isoxazolines as inhibitors of fatty acid amide hydrolase
#100 | 2011-01-13 ✅ Patent 8,716,479 granted on 2014-05-06Methods for stereoselective reduction
Also check out Infinity Pharmaceuticals, Inc.'s (Cambridge, United States) applicant profile with 61 patent applications submitted.
7362 ⎘